TGFB1 and Fabry disease: In addition, TGFβ1 and vascular endothelial growth factor (VEGF-A) have also been noted to be biomarkers of FD associated cardiomyopathy, which is the chronic stage of the disease as evidenced by left ventricular hypertrophy, fibrosis and arrhythmias (48).